Early studies showed enhanced serum levels of TNF-α, VEGF and proMMP-9 in patients with CLL [47,48,49], in correlation with their overexpression and release by CLL lymphocytes [49,50,51] and their implication in CLL cell survival [37,50,52,53]. The gene discussed is TNF; the disease is B-cell chronic lymphocytic leukemia.